AmerisourceBergen Corp.

Build A Healthier Portfolio With These 5 Stocks

More money for meetings (and drugs for free)…

4 Stock Strategies From Wall Street: Feb. 9 (Update 1)

Argus Research's healthcare analyst holds a conference call

AmerisourceBergen Corp. (ABC) Declares $0.13 Quarterly Dividend; 1.3% Yield

AmerisourceBergen Approves Quarterly Dividend

ABC reports $20.4 billion in Q1 revenue

AmerisourceBergen's CEO Discusses Q1 2012 Results - Earnings Call Transcript

AmerisourceBergen 1st-quarter net income climbs

AmerisourceBergen Posts EPS In Line - Analyst Blog

AmerisourceBergen Posts EPS In Line

AmerisourceBergen Reports $0.62 in Diluted EPS, a 9% Percent Increase, and Revenue of $20.4 Billion for the December Quarter

Amerisourcebergen Corp. (ABC) Misses Q1 EPS by 1c

AmerisourceBergen reaffirms FY12 EPS view $2.74-$2.84 vs. consensus $2.82

AmerisourceBergen reports Q1 EPS 62c vs. consensus 63c

AmerisourceBergen Reports $0.62 in Diluted EPS, a 9% Percent Increase, and Revenue of $20.4 Billion for the December Quarter

Companies reporting Before the Market Open on Thursday, January 26

Forbes Earnings Preview: AmerisourceBergen

AmerisourceBergen: Consistently Steady Earnings Growth

AmerisourceBergen Offers Steady Earnings Growth in Good Times and Bad

Anderson Packaging Receives 2011 Illinois Performance Excellence (ILPEx) Silver Award for Progress Toward Excellence

Anderson Packaging Receives 2011 Illinois Performance Excellence (ILPEx) Silver Award for Progress Toward Excellence

AmerisourceBergen offers rising profits, growing dividend, Barron's contends

UBS Maintains a 'Buy' on AmerisourceBergen (ABC); Lower F2013-14 EPS For Generics + Medco

McKesson’s CEO — Successful, But Not Earning His Paycheck

AmerisourceBergen Announces Date and Time for Fiscal First Quarter Earnings Release

AmerisourceBergen Announces Date and Time for Fiscal First Quarter Earnings Release

AmerisourceBergen Announces Date and Time for Fiscal First Quarter Earnings Release

Is McKesson's Stock a Bargain by the Numbers?

US Bioservices Receives URAC Specialty Pharmacy Accreditation

US Bioservices Receives URAC Specialty Pharmacy Accreditation

AmerisourceBergen Backs FY12 View - Analyst Blog

AmerisourceBergen Backs FY12 View

AmerisourceBergen To Reaffirm 2012 Outlook At Investor Meet

AmerisourceBergen Reaffirms Guidance for Fiscal Year 2012 at Annual Investor Day

AmerisourceBergen affirms FY12 EPS view $2.74-$2.84 vs. consensus $2.81

AmerisourceBergen (ABC) Reiterates FY12 Outlook During Annual Investor Day

AmerisourceBergen Reaffirms Guidance for Fiscal Year 2012 at Annual Investor Day

How Does McKesson Boost Its Returns?

7 âBabyâ Booming Health Care Stocks to Buy Now